Efficacy of Botulinum Toxin Type A for Treating Chronic Low Back Pain
| Author | Seyed M. Jazayeri | en |
| Author | Alireza Ashraf | en |
| Author | Habib M. Fini | en |
| Author | Hajar Karimian | en |
| Author | Mohamadreza V. Nasab | en |
| Issued Date | 2011-12-31 | en |
| Abstract | Background: Low back pain is a major cause of disability and can result in substantial morbidity Objectives: The aim of this study was to investigate the efficacy of botulinum toxin type A Patients and Methods: This was a single-blind, randomized clinical trial study. Fifty patients with CLBP Results: After 4 weeks, 76% of patients in the BoNT-A group reported pain relief compared to 20% Conclusions: BoNT-A improves CLBP with a low incidence of side effects and can be used as a | en |
| DOI | https://doi.org/10.5812/kowsar.22287523.1845 | en |
| URI | https://brieflands.com/journals/aapm/articles/17288 | en |
| Keyword | Botulinum toxin type A | en |
| Keyword | Low back pain | en |
| Keyword | Pain | en |
| Publisher | Brieflands | en |
| Title | Efficacy of Botulinum Toxin Type A for Treating Chronic Low Back Pain | en |
| Type | Research Article | en |